Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS2 | Q07890 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 6/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | MPO | P05164 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | TNF | P01375 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369774 | 1.00 | SOS2 (0.68) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL2033277 | 1.00 | SOS2 (0.68) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL29405720 | 1.00 | SOS2 (0.68) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL10023253 | 1.00 | SOS2 (0.68) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL10068458 | 0.89 | SOS2 (0.68) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL28902203 | 0.89 | KDM4E (0.59) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL28902202 | 0.89 | KDM4E (0.59) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL21644779 | 0.86 | MAPT (0.62) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL21644780 | 0.86 | MAPT (0.62) | SOS2MAPTKMT2AKDM4ELMNA | |
| SCHEMBL29379020 | 0.86 | MAPT (0.62) | SOS2MAPTKMT2AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144842-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS | TEMPLE OTORONGO LLC (US) | 2026-05-28 | — | — | US | claimed |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| CN-118406439-B | Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing | 万华化学集团电子材料有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118406439-A | Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing | 万华化学集团电子材料有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118184756-A | Engineered Leptospira perfoliatum lectin mutant and application thereof | 浙江大学医学院附属第一医院(浙江省第一医院) | 2024-06-14 | — | — | CN | claimed |
| CN-114940979-B | Method for improving cation-pi interaction by utilizing genetic code expansion and application | 杭州嵌化合生医药科技有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-11845808-B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | JANSSEN BIOTECH, INC. (US) | 2023-12-19 | — | — | US | claimed |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2023-04-13 | — | — | US | claimed |
| US-20080028488-A1 | USE OF TRYPTOPHAN INDOLE AND ANTHRANILATE ANALOGS AS PLANT TRANSFORMATION SELECTION AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2008-01-31 | — | — | US | claimed |
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | EPIX PHARMACEUTICALS, INC. | 2007-12-20 | — | — | US | claimed |
| WO-2007084264-A2 | METHODS FOR MYOCARDIAL IMAGING | EPIX PHARMACEUTICALS, INC. (US) | 2007-07-26 | — | — | WO | claimed |
| EP-1101823-A2 | Process for the preparation of indigo derivatives and dyes for ceratinous fibers containing the same | Wella Aktiengesellschaft (DE) | 2001-05-23 | — | — | EP | claimed |
| EP-1029073-A1 | METHOD AND AGENT FOR DETERMINING AN ENZYMATIC ACTIVITY SUCH AS DEAMINASE | BIO MERIEUX (FR) | 2000-08-23 | — | — | EP | claimed |
| WO-1999024604-A1 | METHOD AND AGENT FOR DETERMINING AN ENZYMATIC ACTIVITY SUCH AS DEAMINASE | BIO MERIEUX (FR) | 1999-05-20 | — | — | WO | claimed |
| US-5034318-A | Culturing Coryneform glutamic acid producing bacteria with plasmids | AJINOMOTO CO., INC. (JP) | 1991-07-23 | — | — | US | claimed |
| EP-0192948-A1 | Cholecystokinin antagonist compounds, process for their preparation and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1986-09-03 | — | — | EP | claimed |
| US-3963572-A | Fermentative process for the production of L-tryptophan and its derivatives | AB BOFORS (SW) | 1976-06-15 | — | — | US | claimed |
| US-3930948-A | ENZYMATIC METHOD FOR PRODUCING AROMATIC ETHYLAMINES | AJINOMOTO CO., INC. (JA) | 1976-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | DNPEP, NPEPPS, PAM | SOS2 2068/4885MAPT 1350/4885KMT2A 1848/4885 |
| US-20260144842-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS | OPRK1, TPH1, HTR3C | SOS2 4035/4885MAPT 1093/4885KMT2A 4104/4885 |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | TST, ABAT, AADAC | SOS2 4848/4885MAPT 1493/4885KMT2A 1523/4885 |
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | COL14A1, COL2A1, COL1A1 | SOS2 3918/4885MAPT 1814/4885KMT2A 4714/4885 |
| US-11845808-B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | IL23R, IL1RN, VIP | SOS2 3562/4885MAPT 2759/4885KMT2A 4527/4885 |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | MET, THRB, ABAT | SOS2 4567/4885MAPT 1679/4885KMT2A 2188/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | SOS2 4316/4885MAPT 1809/4885KMT2A 3415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.